Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110
Author
Morise, M.
Andric, Z.
Geater, S.
ÖZGÜROĞLU, Mustafa
Mocci, S.
McCleland, M.
Zou, W.
Enquist, I.
Komatsubara, K.
Kuriki, H.
Deng, Y.
Herbst, R. S.
De Marinis, F.
Giaccone, G.
Stahel, R.
Reinmuth, N.
Vergnenegre, A.
Barrios, C. H.
Felip, E.
Jassem, J.
Spigel, D.
Metadata
Show full item recordCollections
- Makale [92796]